Infectious Diseases Research Collaboration, Kampala, Uganda.
Department of Medicine, Makerere University, College of Health Sciences, Kampala, Uganda.
Am J Trop Med Hyg. 2022 Oct 11;107(4_Suppl):21-32. doi: 10.4269/ajtmh.21-1285.
The Program for Resistance, Immunology, Surveillance, and Modeling of Malaria (PRISM) has been conducting malaria research in Uganda since 2010 to improve the understanding of the disease and measure the impact of population-level control interventions in the country. Here, we will summarize key research findings from a series of studies addressing routine health facility-based surveillance, comprehensive cohort studies, studies of the molecular epidemiology, and transmission of malaria, evaluation of antimalarial drug efficacy, and resistance across the country, and assessments of insecticide resistance. Among our key findings are the following. First, we found that in historically high transmission areas of Uganda, a combination of universal distribution of long-lasting insecticidal-treated nets (LLINs) and sustained indoor residual spraying (IRS) of insecticides lowered the malaria burden greatly, but marked resurgences occurred if IRS was discontinued. Second, submicroscopic infections are common and key drivers of malaria transmission, especially in school-age children (5-15 years). Third, markers of drug resistance have changed over time, with new concerning emergence of markers predicting resistance to artemisinin antimalarials. Fourth, insecticide resistance monitoring has demonstrated high levels of resistance to pyrethroids, appreciable impact of the synergist piperonyl butoxide to pyrethroid susceptibility, emerging resistance to carbamates, and complete susceptibility of malaria vectors to organophosphates, which could have important implications for vector control interventions. Overall, PRISM has yielded a wealth of information informing researchers and policy-makers on the malaria burden and opportunities for improved malaria control and eventual elimination in Uganda. Continued studies concerning all the types of surveillance discussed above are ongoing.
疟疾抵抗、免疫、监测和建模项目(PRISM)自 2010 年以来一直在乌干达开展疟疾研究,以增进对该疾病的了解,并衡量该国人群层面控制干预措施的影响。在此,我们将总结一系列研究的主要研究结果,这些研究涉及常规卫生机构监测、综合队列研究、疟疾分子流行病学和传播研究、抗疟药物疗效评估以及全国范围的抗药性评估和杀虫剂耐药性评估。我们的主要发现如下。首先,我们发现,在乌干达历史上高传播地区,普遍发放长效驱虫蚊帐(LLINs)和持续室内滞留喷洒(IRS)杀虫剂大大降低了疟疾负担,但如果停止 IRS,疟疾负担会显著反弹。其次,亚临床感染很常见,是疟疾传播的主要驱动因素,尤其是在学龄儿童(5-15 岁)中。第三,耐药标志物随时间发生变化,新出现的抗青蒿素药物耐药标志物令人担忧。第四,杀虫剂耐药性监测表明对拟除虫菊酯的耐药性很高,增效剂胡椒基丁醚对拟除虫菊酯敏感性有明显影响,对氨基甲酸酯的耐药性逐渐出现,疟疾传播媒介对有机磷酸酯类完全敏感,这可能对病媒控制干预措施产生重要影响。总体而言,PRISM 提供了大量信息,为研究人员和决策者提供了疟疾负担以及改善乌干达疟疾控制和最终消除疟疾的机会。关于上述所有类型监测的持续研究正在进行中。